<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38416635</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2578-5478</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Photobiomodulation, photomedicine, and laser surgery</Title><ISOAbbreviation>Photobiomodul Photomed Laser Surg</ISOAbbreviation></Journal><ArticleTitle>Photobiomodulation in the Treatment of Dysgeusia in Patients with Long COVID: A Single-Blind, Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>215</StartPage><EndPage>224</EndPage><MedlinePgn>215-224</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/photob.2023.0148</ELocationID><Abstract><AbstractText><b><i>Objective</i>:</b> The aim of this study is to evaluate local and systemic photobiomodulation (PBM) in patients with COVID-19-related dysgeusia, with the expectation of improving taste dysfunction. <b><i>Background</i>:</b> PBM has garnered attention as a potential therapy in long COVID, a condition characterized by many persistent symptoms following the acute phase of COVID-19. Among these symptoms, dysgeusia, or altered taste perception, can significantly affect patients' quality of life. Emerging research suggests that PBM may hold promise in ameliorating dysgeusia by modulating cellular processes and reducing inflammation. Further clinical studies and randomized controlled trials are essential to establish the efficacy and safety of PBM for the treatment of dysgeusia in long COVID, but initial evidence suggests that this noninvasive modality may offer a novel avenue for symptom management. <b><i>Methods</i>:</b> Seventy patients experiencing dysgeusia were randomly assigned to receive active local and systemic PBM (<i>n</i>&#x2009;=&#x2009;34) or simulated PBM (<i>n</i>&#x2009;=&#x2009;36). Low-power laser (red wavelength) was used at 18 spots on the lateral borders of the tongue (3&#x2009;J per spot), salivary glands (parotid, sublingual, and submandibular glands-3&#x2009;J per spot), and over the carotid artery for 10&#x2009;min (60&#x2009;J). Alongside laser therapy, all patients in both groups received weekly olfactory therapy for up to 8 weeks. <b><i>Results</i>:</b> Dysgeusia improved in both groups. At weeks 7 and 8, improvement scores were significantly higher in the PBM group than in the sham group (<i>p</i>&#x2009;=&#x2009;0.048). <b><i>Conclusions</i>:</b> Combined local and systemic PBM, as applied in this study, proved effective and could serve as a viable treatment option for alleviating dysgeusia in long-COVID patients. Clinical Trial Registration: RBR-2mfbkkk.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Parreira</LastName><ForeName>Let&#xed;cia Fernandes Sobreira</ForeName><Initials>LFS</Initials><AffiliationInfo><Affiliation>Postgraduate Program in Health Sciences, Center for Life Sciences, Pontif&#xed;cia Universidade Cat&#xf3;lica de Campinas (PUC-Campinas), Campinas, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinheiro</LastName><ForeName>S&#xe9;rgio Luiz</ForeName><Initials>SL</Initials><Identifier Source="ORCID">0000-0001-7157-4923</Identifier><AffiliationInfo><Affiliation>Postgraduate Program in Health Sciences, Center for Life Sciences, Pontif&#xed;cia Universidade Cat&#xf3;lica de Campinas (PUC-Campinas), Campinas, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fontana</LastName><ForeName>Carlos Eduardo</ForeName><Initials>CE</Initials><Identifier Source="ORCID">0000-0002-2868-6839</Identifier><AffiliationInfo><Affiliation>Postgraduate Program in Health Sciences, Center for Life Sciences, Pontif&#xed;cia Universidade Cat&#xf3;lica de Campinas (PUC-Campinas), Campinas, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Photobiomodul Photomed Laser Surg</MedlineTA><NlmUniqueID>101734781</NlmUniqueID><ISSNLinking>2578-5478</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004408" MajorTopicYN="N">Dysgeusia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D028022" MajorTopicYN="Y">Low-Level Light Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">dysgeusia</Keyword><Keyword MajorTopicYN="N">low-level light therapy</Keyword><Keyword MajorTopicYN="N">photobiomodulation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>28</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>28</Day><Hour>12</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38416635</ArticleId><ArticleId IdType="doi">10.1089/photob.2023.0148</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>